MacroGenics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for MacroGenics, Inc. (MGNX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-66.97-9.06-119.76-202.12-129.74-151.81-171.45
Depreciation & Amortization7.549.6511.8712.8711.7010.859.16
Stock Based Compensation29.4418.3720.4423.1320.680.000.00
Change in Working Capital1.3953.32-6.1323.78-13.21-15.76-6.58
Change in Accounts Receivable6.0645.86-45.8412.70-10.340.000.00
Change in Inventory-2.190.230.06-6.420.000.000.00
Change in Accounts Payable-1.531.28-10.867.133.720.000.00
Change in Other Working Capital8.47-145.596.22-5.090.550.000.00
Other Operating Activities-0.66-145.596.2221.6419.3522.450.00
Net Cash from Operating Activities-68.37-78.21-86.96-143.83-111.90-134.27-153.23
Investing Activities
Capital Expenditures-3.71-1.76-3.626.205.914.29-24.95
Purchases of Investments112.84-239.68-120.60-30.41-1.880.000.00
Sales/Maturities of Investments190.03161.30194.94-30.41-1.88-75.0781.60
Other Investing Activities40.000.000.000.000.000.000.00
Net Cash from Investing Activities149.30-80.0870.72-36.61-7.79-79.3656.64
Financing Activities
Common Stock Issued3.440.621.09117.82170.46118.66103.26
Common Stock Repurchased-2.48-0.310.000.000.000.000.00
Other Financing Activities-2.48149.190.000.00-2.010.000.00
Net Cash from Financing Activities0.96150.361.66122.78174.34119.97104.99
Summary
Net Change in Cash81.88-7.93-14.59-57.6654.66-93.668.40
Cash at Beginning of Period100.96108.88123.47181.13126.47220.13211.73
Cash at End of Period182.84100.96108.88123.47181.13126.47220.13
Free Cash Flow-72.08-79.97-90.58-150.03-117.80-138.56-178.19
Supplemental Disclosures
Income Taxes Paid0.940.000.000.000.000.000.00